On ECHEMI
Home > Drugs > Neonatal respiratory distress syndrome
Neonatal respiratory distress syndrome
Neonatal respiratory distress syndrome (NRDS), also known as hyaline miembrane disease (HMD), refers to the progressive dyspnea, cyanosis, expiratory groaning, inspiratory concave sign and respiratory failure that occur soon after birth. It is mainly seen in premature infants, especially those with a gestational age of less than 32 to 33 weeks. The basic characteristics are progressive alveolar atelectasis caused by immature lungs and lack of pulmonary surfactant, impaired pulmonary fluid transport, and high permeability exudative lesions between pulmonary capillaries and alveoli. The pathological feature is the presence of eosinophilic hyaline membranes on the alveolar walls to the terminal bronchioles.
  • Site of disease:

    lung
  • Infectious :

    Not contagious
  • Frequent population:

    It is common within 4 to 12 hours after birth, and premature infants...
  • Related symptoms:

    Difficulty breathing Cyanosis of newborn Blue complexion Cyanosis around the mouth and nose Acute dyspnea
  • Concurrent disease:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.